Navamedic ASA: Trading Update

Navamedic ASA has entered into a market making agreement with Norne Securities AS

Navamedic ASA: Q3 2021 financial results

Navamedic ASA: Invitation to 2021 Third quarter presentation

Navamedic ASA extends exclusive distribution rights for Mysimba in the Nordics

Navamedic ASA receives approval for conditional reimbursement for Mysimba® in Finland